ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2236

Association of microRNA-30b Plasma Expression with Fibromyalgia Clinical Features and with Corneal Small Nerve Fiber Pathology

Laura Aline Martínez Martínez1, Fausto Sánchez Muñoz1, Manuel Ramírez Fernández2, Yaneli Juárez Vicuña1, Mario Peña-Peña1, Carlos Alfonso Guzman Martin1, Itzel Palafox Sosa1 and Manuel Martínez-Lavín1, 1Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico, 2APEC Hospital de la ceguera, Ciudad de México, Mexico

Meeting: ACR Convergence 2022

Keywords: fibromyalgia, Micro-RNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Fibromyalgia and Other Clinical Pain Syndromes

Session Type: Abstract Session

Session Time: 4:30PM-5:30PM

Background/Purpose: There is a clear association between fibromyalgia and small fiber neuropathy. Dorsal root ganglia contain the small nerve fiber nuclei. Severe fibromyalgia is associated to particular dorsal root ganglia Nav1.7 sodium channel gen polymorphism [Vargas-Alarcón et al. BMC Musculoskelet Disord 2012; 13;23]. Corneal confocal microscopy unveiled small nerve fiber pathology in fibromyalgia patients [Ramirez et al. Semin Arthritis Rheum. 2015: 45;214]. MicroRNA-30b strongly regulates expression of dorsal root ganglia Nav1.7 sodium channel in nerve injury-induced neuropathic pain in the rat [Shao et al. Mol Pain 2016: 12; 1]. MicroRNA plasma levels are potential disease biomarkers. The aim of this study was to explore the association of MicroRNA-30b plasma levels with fibromyalgia clinical features and with corneal small nerve fiber abnormalities.

Methods: We studied 46 adult women suffering from fibromyalgia without metabolic or autoimmune comorbidities and 26 age, sex, and body mass index matched healthy women. All individuals filled the following questionnaires: Revised Fibromyalgia Impact, Widespread Pain Index, Severity Symptom Score, Poly-symptomatic Distress Scale, Dysautonomia (COMPASS-31), neuropathic pain (LANSS), small fiber neuropathy, anxiety (GADS-7), depression (PHQ9), and quality of life (EuroQol). Twenty-eight fibromyalgia patients underwent corneal confocal microscopy searching for small nerve fiber pathology.

MicroRNA-30b was detected with primer specific cDNA synthesis and TaqMan probes from Applied Biosystems followed by qPCR. Plasma microRNA abundance was expressed as 50-target miRNA Cq values and by means of 2-(Cq target-Cq miR-16) formula.

Results: In the fibromyalgia cohort, microRNA-30b plasma levels displayed significant correlation with the following features: Corneal small nerve fiber tortuosity (Rho=-0.380, p=0.046), disease chronicity (Rho=0.306, p=0.039), fatigue (Rho=0.302, p=0.041), bladder symptoms (Rho=0.333, p=0.024), depression (Rho=0.397, p=0.006) and anxiety (Rho=0.448, p=0.002). The difference in microRNA-30b plasma levels between patients and controls had borderline significance (p=0.085).

Conclusion: The correlation between microRNA-30b plasma levels and corneal small nerve fiber tortuosity suggest that this short segment of RNA plays a role in human neuropathic pain. MicroRNA-30b may play a role in fibromyalgia pathogenesis.


Disclosures: L. Martínez Martínez, None; F. Sánchez Muñoz, None; M. Ramírez Fernández, None; Y. Juárez Vicuña, None; M. Peña-Peña, None; C. Guzman Martin, None; I. Palafox Sosa, None; M. Martínez-Lavín, None.

To cite this abstract in AMA style:

Martínez Martínez L, Sánchez Muñoz F, Ramírez Fernández M, Juárez Vicuña Y, Peña-Peña M, Guzman Martin C, Palafox Sosa I, Martínez-Lavín M. Association of microRNA-30b Plasma Expression with Fibromyalgia Clinical Features and with Corneal Small Nerve Fiber Pathology [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/association-of-microrna-30b-plasma-expression-with-fibromyalgia-clinical-features-and-with-corneal-small-nerve-fiber-pathology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-microrna-30b-plasma-expression-with-fibromyalgia-clinical-features-and-with-corneal-small-nerve-fiber-pathology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology